文献速递眼底病与葡萄膜炎青光眼白内障与屈光手术

局部前列腺素类似物使用与白内障术后黄斑囊样水肿:随机对照试验

Topical prostaglandin analogue use and cystoid macular oedema following uneventful cataract surgery: a randomised control trial.
PubMed 文献 · Br J Ophthalmol · 2021-05-27

这项前瞻性随机对照试验纳入62眼(62例)使用前列腺素类似物(PGA)且伴高眼压症或原发性开角型青光眼的白内障手术患者,随机分为术后继续PGA组(n=31)与停用PGA组(n=31)。术后1个月黄斑囊样水肿(CMO)发生率两组均为12.9%(4/31眼),继续PGA组术后1个月眼压较基线显著降低。结论提示在黄斑形态正常的眼中,无并发症白内障术后继续PGA未增加CMO发生率。

要点

  • 无并发症白内障术后继续PGA者1个月CMO发生率为12.9%,与停用者相同。
  • 继续PGA组术后1个月眼压较基线显著降低。
  • 黄斑形态正常且无其他CMO危险因素时,可按需继续PGA。

核心结论

  • 在黄斑形态正常且无并发症白内障术后,继续使用PGA未增加CMO发生率。
  • 继续PGA在术后1个月显著降低眼压,提示有指征时可考虑继续使用。

研究设计与样本

  • 前瞻性随机对照试验,纳入62眼(62例)既往使用PGA的高眼压症或原发性开角型青光眼患者。
  • 随机分为术后继续PGA组(n=31)与停用PGA组(n=31)。
  • 主要终点为术后1个月由设盲观察者基于OCT判定的CMO发生。
  • 次要终点为眼压较基线的变化。

主要发现

  • 术后1个月CMO发生率两组均为12.9%(4/31眼),OR 1.000(95%CI 0.227至4.415)。
  • 术后1个月继续PGA组眼压较基线显著降低。

临床怎么用

  • 对使用PGA的原发性开角型青光眼或高眼压症患者,无并发症白内障术后在无其他CMO危险因素时可考虑继续PGA。
  • 术后1个月应关注CMO发生并评估眼压变化。

局限性

  • 样本量较小(62眼)。
  • 仅评估术后1个月CMO发生。
  • 研究人群为黄斑形态正常者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: The association between the development of cystoid macular oedema (CMO) following uneventful cataract surgery and prostaglandin analogue (PGA) therapy has not been fully determined. The study aim was to investigate whether discontinuation of PGA therapy following uneventful cataract surgery affected the incidence of postoperative CMO. METHODS: A prospective randomised controlled trial of 62 eyes of 62 participants with ocular hypertension (OH) or primary open angle glaucoma (POAG) treated with PGAs prior to cataract surgery. Participants were randomised to continue with PGA therapy after cataract surgery (CPGA) (n=31) or to discontinue PGA therapy (n=31). The primary outcome measure was the development of CMO at 1-month postoperatively, determined by a masked observer assessment of optical coherence tomography scans. The secondary outcome measure was change from baseline intraocular pressure (IOP). RESULTS: The incidence of CMO was identical in both groups at 12.9% (4 of 31 eyes) at the 1-month postoperative visit (OR 1.000; 95% CI 0.227 to 4.415). At 1-month postoperatively, the IOP was significantly lower in the CPGA group compared with baseline IOP. CONCLUSION: Continuation of PGA therapy following uneventful cataract surgery in eyes with normal macular morphology did not increase the incidence of CMO. Continuation of PGA therapy significantly reduced IOP at 1-month postoperatively suggesting that, when indicated, it might be beneficial to continue PGA therapy in patients with POAG or OH after uneventful cataract surgery in the absence of other risk factors for developing CMO.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Niyadurupola N, Brodie J, Patel T, et al. Topical prostaglandin analogue use and cystoid macular oedema following uneventful cataract surgery: a randomised control trial. Br J Ophthalmol. 2021. PMID: 34045222. doi:10.1136/bjophthalmol-2021-319149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。